Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetazolamide: future perspective in topical glaucoma therapeutics.

Indu Pal Kaur1, R Smitha, Deepika Aggarwal

  • 1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India. indupalkaur@yahoo.com

International Journal of Pharmaceutics
|November 14, 2002
PubMed
Summary

Acetazolamide (ACZ) can be reformulated for topical glaucoma treatment using advanced ocular drug delivery methods. These novel formulations aim to improve efficacy and reduce side effects compared to existing treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immobilized bacterial cell technology for sustainable industrial wastewater treatment: a review.

3 Biotech·2026
Same author

Therapeutic plasma exchange in acute liver failure: Unravelling its efficacy and impact.

Hematology, transfusion and cell therapy·2026
Same author

Sesamol as a multifunctional antioxidant in tissue injury and repair: mechanistic insights and therapeutic perspectives.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

ROS-responsive drug delivery systems: Harnessing redox biology for targeted therapies.

Colloids and surfaces. B, Biointerfaces·2026
Same author

The surface-first paradigm: Engineering nanocarriers for infection-responsive drug delivery.

Advances in colloid and interface science·2026
Same author

Analysis of Titers of Immunoglobulin M and Immunoglobulin G ABO Antibodies in Group O Blood and Plateletphersis Donors at a Tertiary Care Hospital.

Annals of African medicine·2025

Area of Science:

  • Ophthalmology
  • Pharmaceutics
  • Drug Delivery

Background:

  • Acetazolamide (ACZ) is an established glaucoma treatment with significant side effects and poor topical effectiveness.
  • Current topical carbonic anhydrase inhibitors (CAIs) like dorzolamide and brinzolamide offer localized effects but can still cause systemic adverse reactions.

Purpose of the Study:

  • To review newer formulation approaches for developing effective topical acetazolamide (ACZ) for glaucoma treatment.
  • To explore strategies for enhancing ACZ solubility, penetration, and bioavailability for ocular delivery.

Main Methods:

  • Review of existing studies on advanced ocular drug delivery systems for acetazolamide.
  • Analysis of formulation strategies including high drug concentration, surfactant gels, liposomes, cyclodextrins, and polymers.

Related Experiment Videos

Main Results:

  • Formulation strategies like liposomes, cyclodextrins, and polymer-based systems show promise for effective topical ACZ delivery.
  • Despite lower IC50 values for dorzolamide, oral ACZ demonstrates greater physiological effectiveness than topical dorzolamide.

Conclusions:

  • Advanced formulation technologies offer significant potential for developing more effective, safer, and cost-efficient topical acetazolamide formulations.
  • Further research into these novel delivery systems can revitalize the development of topical ACZ for glaucoma management.